Enhanced neuroprotective efficacy of bone marrow mesenchymal stem cells co-overexpressing BDNF and VEGF in a rat model of cardiac arrest-induced global cerebral ischemia.

作者: Lili Zhou , Qingming Lin , Peng Wang , Lan Yao , Kahong Leong

DOI: 10.1038/CDDIS.2017.184

关键词:

摘要: Cardiac arrest-induced global cerebral ischemia injury (CA-GCII) usually leads to a poor neurological outcome without an effective treatment. Bone marrow-derived mesenchymal stem cells (BMMSCs) may provide potential cell-based therapy against neurologic disorders through induction of brain-derived neurotrophic factor (BDNF) and vascular endothelial growth (VEGF). To optimize the neuroprotective efficacy BMMSCs further, in this study we have derived BMMSCs, which co-overexpress both BDNF VEGF, tested them for treatment CA-GCII rat model. Lentiviruses that express exon IV or VEGF-A were created using bicistronic shuttle vectors pLVX-IRES-ZsGreen1 pLVX-IRES-tdTomato, respectively. co-transduced with engineered lentiviruses co-overexpression VEGF along corresponding fluorescent protein reporters injected via jugular vein rats just recovered from cardiac arrest. Animals then scored neurofunctional deficits examined brain pathology gene expression relevant engraftment seven days after treatments. We demonstrate anchorage lentiviral vector-transduced co-overexpressed hippocampus temporal cortex significantly ameliorated improved performance transplantation. These findings proof concept further validation patients clinical practice future.

参考文章(61)
Emi Kumamaru, Hiroshi Kunugi, Naoki Adachi, Shingo Suzuki, Misty Richards, Tadahiro Numakawa, BDNF function and intracellular signaling in neurons. Histology and Histopathology. ,vol. 25, pp. 237- 258 ,(2010) , 10.14670/HH-25.237
Michael Levy, Nicholas Boulis, Mahendra Rao, Clive N. Svendsen, Regenerative cellular therapies for neurologic diseases Brain Research. ,vol. 1638, pp. 88- 96 ,(2016) , 10.1016/J.BRAINRES.2015.06.053
Barbara L Hempstead, Brain-Derived Neurotrophic Factor: Three Ligands, Many Actions. Transactions of the American Clinical and Climatological Association. ,vol. 126, pp. 9- 19 ,(2015)
Amara Larpthaveesarp, Donna Ferriero, Fernando Gonzalez, Growth factors for the treatment of ischemic brain injury (growth factor treatment). Brain Sciences. ,vol. 5, pp. 165- 177 ,(2015) , 10.3390/BRAINSCI5020165
Jennifer J. Bara, R. Geoff Richards, Mauro Alini, Martin J. Stoddart, Concise Review: Bone Marrow‐Derived Mesenchymal Stem Cells Change Phenotype Following In Vitro Culture: Implications for Basic Research and the Clinic Stem Cells. ,vol. 32, pp. 1713- 1723 ,(2014) , 10.1002/STEM.1649
Micah A. Chrenek, Jeffrey H. Boatright, John M. Nickerson, Lennart Berglin, Christiana J. Johnson, T.M. Redmond, Technical Brief: Subretinal injection and electroporation into adult mouse eyes Molecular Vision. ,vol. 14, pp. 2211- 2226 ,(2008)
Matthew T. Harting, Fernando Jimenez, Hasan Xue, Uwe M. Fischer, James Baumgartner, Pramod K. Dash, Charles S. Cox, Intravenous mesenchymal stem cell therapy for traumatic brain injury. Journal of Neurosurgery. ,vol. 110, pp. 1189- 1197 ,(2009) , 10.3171/2008.9.JNS08158
Anton B Tonchev, Brain ischemia, neurogenesis, and neurotrophic receptor expression in primates. Archives Italiennes De Biologie. ,vol. 149, pp. 225- 231 ,(2011) , 10.4449/AIB.V149I2.1368
Yu-Hui Wong, Chia-Ming Lee, Wenjun Xie, Bianxiao Cui, Mu-ming Poo, Activity-dependent BDNF release via endocytic pathways is regulated by synaptotagmin-6 and complexin. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 112, pp. 201511830- ,(2015) , 10.1073/PNAS.1511830112
T. Jared Bunch, Roger D. White, Bernard J. Gersh, Ryan A. Meverden, David O. Hodge, Karla V. Ballman, Stephen C. Hammill, Win-Kuang Shen, Douglas L. Packer, Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation. The New England Journal of Medicine. ,vol. 348, pp. 2626- 2633 ,(2003) , 10.1056/NEJMOA023053